Table 2 Comparison of cost for clinical management of COVID-19 patients stratified by various demographic and clinical characteristics
From: Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis
Characteristics | Cost per casea (USD, Mean ± SD) | P value |
|---|---|---|
Sex | Â | 0.966 |
 Male | 6637 ± 7040 |  |
 Female | 7165 ± 7847 |  |
Age group (years) | Â | 0.002 |
 0–34 | 2752 ± 2016 |  |
 35–69 | 6850 ± 7339 |  |
 70– | 11 668 ± 8584 |  |
Residence | Â | 0.280 |
 Rural | 8052 ± 8458 |  |
 Urban | 5905 ± 6221 |  |
Pre-existing disease | Â | < 0.001 |
 No | 3619 ± 3243 |  |
 Yes | 9525 ± 8592 |  |
Severity | Â | < 0.001 |
 Mild | 4552 ± 4831 |  |
 Severe | 11 058 ± 9329 |  |
 Critically ill | 16 652 ± 8506 |  |